Sinclair Pharma Regulatory News (SPH)



Regulatory News for Sinclair Pharma (SPH)


Share Price: 28.125Bid: 28.00Ask: 28.25Change: 0.00 (0.00%)No Movement on Sinclair Is Pha
Spread: 0.25Spread as %: 0.89%Open: 28.00High: 28.125Low: 27.7775Yesterday’s Close: 28.125





Holding(s) in Company

Tue, 3rd Apr 2012 16:55

RNS Number : 7641A
Sinclair IS Pharma PLC
03 April 2012
 

?

 

For filings with the FSA include the annex


For filings with issuer exclude the annex



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
ii

Sinclair IS Pharma PLC

 

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights


An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights


Other (please specify):

Change of Investment Manager

X

3. Full name of person(s) subject to the
notification obligation:
iii

AXA Investment Managers SA

4. Full name of shareholder(s)
 (if different from 3.):iv


5. Date of the transaction and date on
which the threshold is crossed or
reached:
v

1 March 2012

6. Date on which issuer notified:

3 April 2012

7. Threshold(s) that is/are crossed or
reached:
vi, vii

11.00 %



 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB0033856740

44,226,155

44,226,155

0

0

41,712,083

0.00 %

10.36 %

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights







C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period
xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 






Nominal

Delta




Total (A+B+C)

Number of voting rights

Percentage of voting rights

41,712,083

10.36 %



 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

 

 


Proxy Voting:

10. Name of the proxy holder:


11. Number of voting rights proxy holder will cease
to hold:


12. Date on which proxy holder will cease to hold
voting rights:




13. Additional information:



14. Contact name:

Dimitrios Tsamis

15. Contact telephone number:

+44 (0) 207 003 2806

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEASLDESAAEFF


Related Shares: Sinclair Is Pharma (SPH).




DateSourceHeadlineCategory
26-Apr-13 07:00RNSHolding(s) in CompanyHolding(s) in Company
12-Apr-13 09:00RNSHolding(s) in CompanyHolding(s) in Company
18-Mar-13 07:00RNSCollaboration and licensing agreementCompany Announcement - General
18-Mar-13 07:00RNSDisposal of Fazol GMergers, Acquisitions and Disposals
12-Feb-13 07:00RNSLicence and Distribution AgreementCompany Announcement - General
12-Feb-13 07:00RNSHalf Yearly ReportResults and Trading Reports
15-Jan-13 07:00RNSHolding(s) in CompanyHolding(s) in Company
11-Jan-13 07:00RNSHolding(s) in CompanyHolding(s) in Company
10-Jan-13 07:00RNSTrading StatementResults and Trading Reports
09-Jan-13 10:00RNSHolding(s) in CompanyHolding(s) in Company
07-Jan-13 15:30RNSHolding(s) in CompanyHolding(s) in Company
21-Dec-12 14:30RNSHolding(s) in CompanyHolding(s) in Company
21-Dec-12 07:30RNSHolding(s) in CompanyHolding(s) in Company
20-Dec-12 07:00RNSDirector/PDMR ShareholdingDirectors' Dealings
20-Dec-12 07:00RNSAmendment of Lock-up termsCompany Announcement - General
19-Dec-12 10:50RNSCollaboration and Licensing AgreementCompany Announcement - General
19-Dec-12 07:00RNSChange of AdviserExecutive Changes
18-Dec-12 10:43RNSDirector/PDMR ShareholdingDirectors' Dealings
08-Nov-12 15:33RNSDirector DealingsDirectors' Dealings
07-Nov-12 12:46RNSAGM StatementResults and Trading Reports
18-Oct-12 07:00RNSAnnual Financial ReportResults and Trading Reports
09-Oct-12 16:32RNSHolding(s) in CompanyHolding(s) in Company
04-Oct-12 18:38RNSHolding(s) in CompanyCompany Announcement - General
01-Oct-12 07:00RNSDistribution agreement and Placing to raise £9mCompany Announcement - General
19-Sep-12 16:39RNSHolding(s) in Company - ReplacementHolding(s) in Company
19-Sep-12 09:51RNSHolding(s) in CompanyHolding(s) in Company
17-Sep-12 10:39RNSHolding(s) in CompanyHolding(s) in Company
13-Sep-12 07:00RNS10-year Partnership with Quintiles in MexicoCompany Announcement - General
13-Sep-12 07:00RNSFinal ResultsResults and Trading Reports
10-Jul-12 07:00RNSTrading StatementResults and Trading Reports


Regulatory news is displayed end of day, each day at 19:00.
Sign up for Live Prices





Datafeed and UK data supplied by NETbuilder and Interactive Data. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.